Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Bad
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
accuracy, agonist, AI, anniversary, artificial, back, built, candidate, Capeserod, Central, claim, CNS, competing, consumer, context, core, creation, cure, degree, denied, diligence, disagreement, empowered, expressed, expressly, face, factor, favor, guarantee, immaterial, implied, incidence, independently, infringe, integration, intelligence, invention, inventorship, involve, involving, Israel, lead, licensor, lose, losing, manner, mechanism, medical, misappropriate, motion, narrow, nonclinical, ownership, parent, pediatric, pivotal, reargue, receptor, refusal, rely, repurpose, resolution, responsibility, revise, Sanofi, schedule, scientific, scope, selective, serve, shareholder, size, strategic, sublicense, sublicensed, sublicensing, successfully, suggest, susceptible, tiered, Type, uncured, underserved, unique, unknown, valid, verified, view, violate
Removed:
initiated, investigational, positive, viral
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view